Literature DB >> 11694691

Childhood hepatitis B virus infections in the United States before hepatitis B immunization.

G L Armstrong1, E E Mast, M Wojczynski, H S Margolis.   

Abstract

OBJECTIVE: To estimate the number of hepatitis B virus (HBV) infections among US children younger than 10 years before implementation of routine childhood hepatitis B immunization.
METHODS: Incidence of HBV infection in children was modeled from existing prevalence data by means of regression analysis. Sources of data for the models included published and unpublished surveys that determined the prevalence of HBV infection in US-born children. The number of nonperinatal HBV infections in children younger than 10 years was estimated by applying these infection rates to 1991 population data according to maternal race, ethnicity, and birthplace.
RESULTS: Estimated annual rates of infection ranged from 24 per 100 000 in non-Asian children to 2580 per 100 000 in children of Southeast Asian immigrant mothers. These rates indicate that by the early 1990s, HBV was infecting 16 000 children who were younger than 10 years (8700 non-Asian children and 7300 Asian-American children) annually. The total estimate, not including perinatal infections, ranged from 12 000 (95% confidence interval: 5500-27 700) to 24 900 (95% confidence interval: 16 700-42 300) infections and depended on how the estimated rates were applied to the population data.
CONCLUSION: Thousands of US children were infected each year with HBV before routine infant hepatitis B immunization, placing them at high risk of death from cirrhosis or hepatocellular carcinoma later in life.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11694691     DOI: 10.1542/peds.108.5.1123

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  Trends in vaccine-induced immunity to hepatitis B among Canadian street-involved youth.

Authors:  Ling Huang; Marie-Line Gilbert; Miriam F Rossi; David Haase; Judith Wright; Nadine Sicard; Carole Beaudoin; Darlene Taylor; Jennifer Gratrix; Lisa Belzak; Tom Wong; Gayatri Jayaraman
Journal:  J Urban Health       Date:  2010-02-20       Impact factor: 3.671

Review 2.  Pediatric issues in new therapies for hepatitis B and C.

Authors:  Kathleen B Schwarz
Journal:  Curr Gastroenterol Rep       Date:  2003-06

3.  Hepatitis B serologic survey and review of immunization records of children, adolescents and adults in Fiji, 2008-2009.

Authors:  Tatsuhiko Tsukakoshi; Josaia Samuela; Eric V Rafai; Uraia Rabuatoka; Sumihisa Honda; Yasuhiko Kamiya; Corazon C Buerano; Kouichi Morita
Journal:  Virol J       Date:  2015-03-03       Impact factor: 4.099

Review 4.  Immunizations in the United States: a rite of passage.

Authors:  Amanda C Cohn; Karen R Broder; Larry K Pickering
Journal:  Pediatr Clin North Am       Date:  2005-06       Impact factor: 3.278

5.  The impact of immigration and vaccination in reducing the incidence of hepatitis B in Catalonia (Spain).

Authors:  Manuel Oviedo; M Pilar Muñoz; Gloria Carmona; Eva Borrás; Joan Batalla; Nuria Soldevila; Angela Domínguez
Journal:  BMC Public Health       Date:  2012-08-06       Impact factor: 3.295

6.  Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation.

Authors:  F Nogareda; Y Le Strat; I Villena; H De Valk; V Goulet
Journal:  Epidemiol Infect       Date:  2013-11-14       Impact factor: 4.434

Review 7.  A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.

Authors:  David B Huang; Jashin J Wu; Stephen K Tyring
Journal:  J Infect       Date:  2004-10       Impact factor: 6.072

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.